Editorial
Individualized clopidogrel suspension strategy coronary artery bypass surgery: what is the best choice?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S969-S971
.
(24 April 2018)
Atlas is not alone: sharing the burden of clinical challenge
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S972-S973
.
(24 April 2018)
Editorial on “enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, openlabel, parallel-group study (NUTRIREA-2)”
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S974-S977
.
(24 April 2018)
Endovascular treatment for chronic type B aortic dissection: current opinions
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S978-S982
.
(24 April 2018)
Improving postoperative pain management after video-assisted thoracic surgery lung resection contributes to enhanced recovery, but guidelines are still lacking
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S983-S987
.
(24 April 2018)
Comparison of proton therapy and intensity modulated photon radiotherapy for locally advanced non-small cell lung cancer: considerations for optimal trial design
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S988-S990
.
(24 April 2018)
Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S991-S994
.
(24 April 2018)
Personalized medicine in immuno-oncology: a novel prognostic index in non-small cell lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S995-S998
.
(24 April 2018)
The intrepid adventure of early transcatheter mitral valve replacement
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S999-S1002
.
(24 April 2018)
Biomarkers in malignant pleural mesothelioma: current status and future directions
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1003-S1007
.
(24 April 2018)
Early experience with transcatheter mitral valve replacement: successes, challenges, and future directions
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1008-S1012
.
(24 April 2018)
The renaissance of photodynamic therapy for early esophageal cancer: is it the time?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1013-S1015
.
(24 April 2018)
Demise of lung transplants: exposing critical gaps in understanding lung stem cells
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1016-S1019
.
(24 April 2018)
Prone positioning in acute respiratory distress syndrome: why aren’t we using it more?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1020-S1024
.
(24 April 2018)
Primary small cell cancer of the esophagus: understanding treatment outcomes
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1025-S1028
.
(24 April 2018)
VATS lobectomy: does surgical heterogeneity prevent evidence on pain control?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1029-S1031
.
(24 April 2018)
Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1032-S1036
.
(24 April 2018)
Surgery for limited-stage primary small cell carcinoma of the esophagus: is it feasible and for whom is it indicated?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1037-S1039
.
(24 April 2018)
Intrepid steps towards clinical prime time
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1040-S1043
.
(24 April 2018)
The management of malignant pleural mesothelioma in the USA 2004-13—a decade of lost opportunity?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1044-S1046
.
(24 April 2018)
Improving the care for elective surgical patients: post-operative ICU admission and outcome
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1047-S1049
.
(24 April 2018)
Analgesic management after thoracoscopic surgery: recent studies and our experience
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1050-S1054
.
(24 April 2018)
From low-dose to no-dose: thin-section magnetic resonance imaging for evaluation of pulmonary nodules
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1055-S1057
.
(24 April 2018)
APRV for ARDS: the complexities of a mode and how it affects even the best trials
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1058-S1063
.
(24 April 2018)
Similar results of robotic and uniportal videothoracoscopic surgery for lung cancer treatment
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1064-S1066
.
(24 April 2018)
New classification—new problems to solve
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1067-S1069
.
(24 April 2018)
Steroids for sepsis: yes, no or maybe
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1070-S1073
.
(24 April 2018)
Unraveling the etiology of primary malignant melanoma of the esophagus
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1074-S1075
.
(24 April 2018)
Moving osimertinib to first-line: the right “strategy” in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1076-S1080
.
(24 April 2018)
Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1081-S1083
.
(24 April 2018)
Biomarkers in malignant mesothelioma—an unfulfilled need or a waste of resources?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1084-S1087
.
(24 April 2018)
Metastasis-associated lung adenocarcinoma transcript 1 regulates tumor progression: old wine in a new bottle
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1088-S1091
.
(24 April 2018)
Improved lymph node staging in early-stage lung cancer in the national cancer database: commentary
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1092-S1095
.
(24 April 2018)
Tri-modality treatment in N2 stage IIIa non-small cell lung cancer: proper sequence remains unknown
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1096-S1098
.
(24 April 2018)
Obstructive sleep apnea and stroke: hand in hand?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1099-S1101
.
(24 April 2018)
Sleep-disordered breathing in the elderly: is it distinct from that in the younger or middle-aged populations?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1102-S1107
.
(24 April 2018)
Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1108-S1112
.
(24 April 2018)
GGO and minimally invasive adenocarcinomas: how to deal with?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1113-S1114
.
(24 April 2018)
Prognostic factors of patients with pathologic stage I lung adenocarcinoma
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1115-S1118
.
(24 April 2018)
Does immunosuppression affect the course of septic shock?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1119-S1121
.
(24 April 2018)
Letter to the Editor
Pan-endoscopic tumor length as the marker to predict response to neoadjuvant therapy for ESCC warrants additional investigation
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1122-S1123
.
(24 April 2018)
Controversies in dose-escalation for locally advanced non-small cell lung cancer and the role of proton beam therapy
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1124-S1126
.
(24 April 2018)
Is the door open to further investigation with antiangiogenesis in SCLC?
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1127-S1128
.
(24 April 2018)
Author’s response to invited commentary “a perspective on the Society of Thoracic Surgeons Composite Score for evaluating esophagectomy for esophageal cancer”
Journal of Thoracic Disease
2018;
10
(Suppl 9)
:S1129-S1130
.
(24 April 2018)
Disclosure:
The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.
